Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AMGN | VRTX | REGN | BMY |
| Company | Apellis Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 42.86 | 312.89 | 420.67 | 970.00 | 44.75 |
| High | 43.06 | 314.89 | 423.32 | 979.98 | 44.97 |
| Low | 41.35 | 309.82 | 417.50 | 966.85 | 44.30 |
| Last | 41.99 | 310.15 | 422.78 | 973.80 | 44.94 |
| Change | -0.53 | -2.71 | +3.79 | +5.80 | +0.20 |
| % Change | -1.25% | -0.87% | +0.90% | +0.60% | +0.45% |
| Volume | 979,700 | 2,611,800 | 1,064,600 | 351,300 | 8,699,500 |
| 20-Day Average Volume | 1,854,030 | 2,930,860 | 1,107,780 | 491,760 | 14,168,375 |
| Previous Close | 42.52 | 312.86 | 418.99 | 968.00 | 44.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 47.15 | 281.61 | 401.94 | 919.00 | 46.01 |
| 20-Day Raw Stochastic | 25.41% | 79.89% | 91.71% | 94.10% | 25.81% |
| 20-Day Relative Strength | 34.51% | 65.95% | 62.31% | 61.33% | 36.90% |
| Weighted Alpha | -29.91 | +34.03 | +22.92 | +31.48 | -34.29 |
| Today's Opinion | 72% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 40% Sell | 24% Buy | 40% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.53% since 05/03/24 | -0.37% since 05/03/24 | +5.41% since 05/03/24 | +1.76% since 05/03/24 | +2.16% since 05/03/24 |
| Low | 41.35 on 05/10/24 | 297.52 on 05/06/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 43.49 on 05/09/24 |
| High | 49.06 on 05/06/24 | 314.89 on 05/10/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 | 44.97 on 05/10/24 |
| 1-Month | |||||
| %Chg | -26.13% since 04/10/24 | +16.40% since 04/10/24 | +6.34% since 04/10/24 | +4.02% since 04/10/24 | -10.64% since 04/10/24 |
| Low | 38.22 on 04/30/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 57.85 on 04/11/24 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 | 50.58 on 04/11/24 |
| 3-Month | |||||
| %Chg | -38.75% since 02/09/24 | +6.54% since 02/09/24 | -0.03% since 02/09/24 | +2.14% since 02/09/24 | -9.78% since 02/09/24 |
| Low | 38.22 on 04/30/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 71.90 on 02/26/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -10.64% since 11/10/23 | +16.03% since 11/10/23 | +13.15% since 11/10/23 | +21.89% since 11/10/23 | -11.20% since 11/10/23 |
| Low | 38.22 on 04/30/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 73.80 on 01/09/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,096,158 | 166,375,312 | 109,099,648 | 106,886,240 | 91,097,872 |
| Shares Outstanding, K | 121,366 | 536,435 | 258,053 | 109,762 | 2,027,100 |
| Annual Sales | 396,590,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -528,630,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 146,380,000 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -88,580,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.97 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.79 | 27.82 | 26.08 | 42.61 |